83 FR 30757 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 83, Issue 126 (June 29, 2018)
National Institutes of Health
Federal Register Volume 83, Issue 126 (June 29, 2018)
| Page Range | 30757-30758 | |
| FR Document | 2018-13967 |
[Federal Register Volume 83, Number 126 (Friday, June 29, 2018)] [Notices] [Pages 30757-30758] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-13967] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; T1D NIDDK Review. Date: June 29, 2018. Time: 9:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Elena Sanovich, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7351, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, 301- 594-8886, sanoviche@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; RFA-DK-17-021: HIRN Consortium on Beta Cell Death and Survival Early T1D Biomarkers Discovery in Human Pancreas. Date: July 23, 2018. Time: 11:00 a.m. to 4:00 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Najma S. Begum, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7349, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-8894, begumn@niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; T1D Clinical Trials Testing Current and Novel Closed Loop Systems (R01). Date: July 24, 2018. Time: 3:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Jason D. Hoffert, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7343, 6707 Democracy Boulevard, Bethesda, MD 20817, 301-496- 9010, hoffertj@niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; RFA-DK-17-020: Immune System Engineering for Targeted Tolerance in Type 1 Diabetes (R01). Date: July 25, 2018. Time: 11:00 a.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Dianne Camp, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7013, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, 301-594-7682, campd@extra.niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; SBIR Phase II Clinical Trials. Date: July 26, 2018. Time: 11:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Thomas A. Tatham, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7021, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-3993, tathamt@mail.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; PAR-18-042: NIDDK Ancillary Studies (R01). Date: July 26, 2018. Time: 11:30 a.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Ann A. Jerkins, Ph.D., Scientific Review Officer, Review Branch, [[Page 30758]] DEA, NIDDK, National Institutes of Health, Room 7119, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 301-594-2242, jerkinsa@niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; RFA-DK-17-022: High Resolution Exploration of the Human Islet Tissue Environment (HIRN)- HPAC. Date: July 30, 2018. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Najma S. Begum, Ph.D., Scientific Review Officer Review Branch, DEA, NIDDK, National Institutes of Health, Room 7349, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-8894, begumn@niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: June 25, 2018. David D. Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018-13967 Filed 6-28-18; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 83, No. 126 / Friday, June 29, 2018 / Notices 30757
based integrated approach to opioid Government will not pay for the Contact Person: Najma S. Begum, Ph.D.,
prevention and treatment services in a preparation of any information Scientific Review Officer, Review Branch,
single community? submitted or for use of that information. DEA, NIDDK, National Institutes of Health,
Health Economics: Room 7349, 6707 Democracy Boulevard,
Dated: June 25, 2018. Bethesda, MD 20892–5452, (301) 594–8894,
• What economic questions should be begumn@niddk.nih.gov.
Lawrence A. Tabak,
included as part of the study to inform
Deputy Director, National Institutes of Health. Name of Committee: National Institute of
systems and policy change? Diabetes and Digestive and Kidney Diseases
Implementation Research: [FR Doc. 2018–14031 Filed 6–28–18; 8:45 am]
Special Emphasis Panel; T1D Clinical Trials
• What implementation research BILLING CODE 4140–01–P
Testing Current and Novel Closed Loop
questions should be included to develop Systems (R01).
best practices for replication in other Date: July 24, 2018.
communities impacted by the opioid DEPARTMENT OF HEALTH AND Time: 3:00 p.m. to 5:00 p.m.
crisis? HUMAN SERVICES Agenda: To review and evaluate grant
• What data should be collected to applications.
help develop metrics for determining National Institutes of Health Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
the quality of an integrated approach to Boulevard, Bethesda, MD 20892 (Telephone
National Institute of Diabetes and
opioid prevention and treatment Conference Call).
Digestive and Kidney Diseases; Notice
services, including policies and Contact Person: Jason D. Hoffert, Ph.D.,
of Closed Meetings
practices? Scientific Review Officer, Review Branch,
• Are there examples of prior Pursuant to section 10(d) of the DEA, NIDDK, National Institutes of Health,
implementation research studies that Federal Advisory Committee Act, as Room 7343, 6707 Democracy Boulevard,
highlight implementation tools that can Bethesda, MD 20817, 301–496–9010,
amended, notice is hereby given of the hoffertj@niddk.nih.gov.
be used to replicate and scale up following meetings.
integrated approaches? Name of Committee: National Institute of
The meetings will be closed to the Diabetes and Digestive and Kidney Diseases
Infrastructure, Partnerships, public in accordance with the Special Emphasis Panel; RFA–DK–17–020:
Collaboration: provisions set forth in sections Immune System Engineering for Targeted
• What research, prevention, and 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Tolerance in Type 1 Diabetes (R01).
treatment infrastructure and as amended. The grant applications and Date: July 25, 2018.
partnerships are needed to support a the discussions could disclose Time: 11:00 a.m. to 4:30 p.m.
community-based pragmatic trial confidential trade secrets or commercial Agenda: To review and evaluate grant
assessing the impact of an evidence- applications.
property such as patentable material, Place: National Institutes of Health, Two
based integrated approach to opioid and personal information concerning
prevention and treatment services? Democracy Plaza, 6707 Democracy
individuals associated with the grant Boulevard, Bethesda, MD 20892 (Telephone
• What is the best approach to
applications, the disclosure of which Conference Call).
fostering collaboration and meaningful
would constitute a clearly unwarranted Contact Person: Dianne Camp, Ph.D.,
participation between state, county, and Scientific Review Officer, Review Branch,
invasion of personal privacy.
local governments; community DEA, NIDDK, National Institutes of Health,
stakeholders; medical/clinical service Name of Committee: National Institute of Room 7013, 6707 Democracy Boulevard,
providers; and researchers? Diabetes and Digestive and Kidney Diseases Bethesda, MD 20892–2542, 301–594–7682,
• How do we construct a research Special Emphasis Panel; T1D NIDDK Review. campd@extra.niddk.nih.gov.
Date: June 29, 2018.
initiative with the highest likelihood of Time: 9:00 a.m. to 1:00 p.m. Name of Committee: National Institute of
having sustainable prevention and Diabetes and Digestive and Kidney Diseases
Agenda: To review and evaluate grant
treatment services? Special Emphasis Panel; SBIR Phase II
applications.
• What data would be of most interest Place: National Institutes of Health, Two
Clinical Trials.
to state and community partners? Date: July 26, 2018.
Democracy Plaza, 6707 Democracy
Time: 11:00 a.m. to 1:00 p.m.
Responses to this RFI are voluntary Boulevard, Bethesda, MD 20892 (Telephone
Agenda: To review and evaluate grant
and may be submitted anonymously. Conference Call).
applications.
Please do not include any personally Contact Person: Elena Sanovich, Ph.D.,
Place: National Institutes of Health, Two
identifiable or other information that Scientific Review Officer, Review Branch,
Democracy Plaza, 6707 Democracy
you do not wish to make public. DEA, NIDDK, National Institutes of Health, Boulevard, Bethesda, MD 20892 (Telephone
Room 7351, 6707 Democracy Boulevard,
Proprietary, classified, confidential, or Bethesda, MD 20892–2542, 301–594–8886,
Conference Call).
sensitive information should not be Contact Person: Thomas A. Tatham, Ph.D.,
sanoviche@mail.nih.gov. Scientific Review Officer, Review Branch,
included in responses. Comments This notice is being published less than 15
submitted will be compiled for DEA, NIDDK, National Institutes of Health,
days prior to the meeting due to the timing Room 7021, 6707 Democracy Boulevard,
discussion and shared internally with limitations imposed by the review and Bethesda, MD 20892–5452, (301) 594–3993,
NIDA, SAMHSA, NIH program staff, funding cycle. tathamt@mail.nih.gov.
and participating leadership across the Name of Committee: National Institute of Name of Committee: National Institute of
Department of Health and Human Diabetes and Digestive and Kidney Diseases Diabetes and Digestive and Kidney Diseases
Services, as appropriate. Any personal Special Emphasis Panel; RFA–DK–17–021: Special Emphasis Panel; PAR–18–042:
identifiers (personal names, email HIRN Consortium on Beta Cell Death and NIDDK Ancillary Studies (R01).
addresses, etc.) will be removed when Survival Early T1D Biomarkers Discovery in Date: July 26, 2018.
Human Pancreas. Time: 11:30 a.m. to 1:30 p.m.
sradovich on DSK3GMQ082PROD with NOTICES
responses are compiled.
This RFI is for informational and Date: July 23, 2018. Agenda: To review and evaluate grant
planning purposes only and is not a Time: 11:00 a.m. to 4:00 p.m. applications.
Agenda: To review and evaluate Place: National Institutes of Health, Two
solicitation for applications or an cooperative agreement applications. Democracy Plaza, 6707 Democracy
obligation on the part of the United Place: National Institutes of Health, Two Boulevard, Bethesda, MD 20892 (Telephone
States Government to provide support Democracy Plaza, 6707 Democracy Conference Call).
for any ideas identified in response to Boulevard, Bethesda, MD 20892 (Telephone Contact Person: Ann A. Jerkins, Ph.D.,
it. Please note that the United States Conference Call). Scientific Review Officer, Review Branch,
VerDate Sep<11>2014 17:58 Jun 28, 2018 Jkt 244001 PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 E:\FR\FM\29JNN1.SGM 29JNN1](https://thefederalregister.org/doc/83_FR_30883/page/1.svg)
![30758 Federal Register / Vol. 83, No. 126 / Friday, June 29, 2018 / Notices
DEA, NIDDK, National Institutes of Health, Place: National Institutes of Health, One ADDRESSES: To avoid duplicate
Room 7119, 6707 Democracy Boulevard, Democracy Plaza, Room 1087, 6701 submissions to the docket, please use
Bethesda, MD 20892–5452, 301–594–2242, Democracy Boulevard, Bethesda, MD 20892 only one of the following means to
jerkinsa@niddk.nih.gov. (Telephone Conference Call). submit comments:
Name of Committee: National Institute of Contact Person: Rahat (Rani) Khan, Ph.D., (1) Online. Submit comments at
Diabetes and Digestive and Kidney Diseases Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
www.regulations.gov under Docket ID
Special Emphasis Panel; RFA–DK–17–022: FEMA–2018–0025. Follow the
High Resolution Exploration of the Human Translational Sciences, 6701 Democracy
Islet Tissue Environment (HIRN)–HPAC. Blvd., Rm 1078, Bethesda, MD 20892, 301– instructions for submitting comments.
Date: July 30, 2018. 594–7319, khanr2@csr.nih.gov. (2) Mail. Submit written comments to
Time: 11:00 a.m. to 3:00 p.m. (Catalogue of Federal Domestic Assistance Docket Manager, Office of Chief
Agenda: To review and evaluate Program Nos. 93.859, Pharmacology, Counsel, DHS/FEMA, 500 C Street SW,
cooperative agreement applications. Physiology, and Biological Chemistry 8NE, Washington, DC 20472–3100.
Place: National Institutes of Health, Two Research; 93.350, B—Cooperative All submissions received must
Democracy Plaza, 6707 Democracy Agreements; 93.859, Biomedical Research include the agency name and Docket ID.
Boulevard, Bethesda, MD 20892 (Telephone and Research Training, National Institutes of Regardless of the method used for
Conference Call). Health, HHS) submitting comments or material, all
Contact Person: Najma S. Begum, Ph.D., Dated: June 25, 2018. submissions will be posted, without
Scientific Review Officer Review Branch, change, to the Federal eRulemaking
DEA, NIDDK, National Institutes of Health, David D. Clary,
Program Analyst, Office of Federal Advisory Portal at http://www.regulations.gov,
Room 7349, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8894, Committee Policy. and will include any personal
begumn@niddk.nih.gov. [FR Doc. 2018–13966 Filed 6–28–18; 8:45 am]
information you provide. Therefore,
(Catalogue of Federal Domestic Assistance
submitting this information makes it
BILLING CODE 4140–01–P
Program Nos. 93.847, Diabetes, public. You may wish to read the
Endocrinology and Metabolic Research; Privacy Act notice that is available via
93.848, Digestive Diseases and Nutrition the link in the footer of
Research; 93.849, Kidney Diseases, Urology DEPARTMENT OF HOMELAND www.regulations.gov.
and Hematology Research, National Institutes SECURITY
FOR FURTHER INFORMATION CONTACT:
of Health, HHS)
Federal Emergency Management Susan Bernstein, Insurance Specialist,
Dated: June 25, 2018. FIMA, Marketing and Outreach Branch,
Agency
David D. Clary, 303–701–3595. You may contact the
Program Analyst, Office of Federal Advisory [Docket ID: FEMA–2018–0025; OMB No. Information Management Division for
Committee Policy. 1660–0040] copies of the proposed collection of
[FR Doc. 2018–13967 Filed 6–28–18; 8:45 am] information at email address: FEMA-
Agency Information Collection Information-Collections-Management@
BILLING CODE 4140–01–P
Activities: Proposed Collection; fema.dhs.gov.
Comment Request; Standard Flood
Hazard Determination Form SUPPLEMENTARY INFORMATION: Section
DEPARTMENT OF HEALTH AND 1365 of the National Flood Insurance
HUMAN SERVICES AGENCY: Federal Emergency Act of 1968 (NFIA) (42 U.S.C. 4104b), as
Management Agency, DHS. added by Section 528 of the National
National Institutes of Health
ACTION: Notice and request for Flood Insurance Reform Act of 1994
National Center for Advancing comments. (Pub. L. 103–325, title V), requires that
Translational Sciences; Notice of FEMA develop a standard hazard
Closed Meeting SUMMARY: The Federal Emergency determination form for recording the
Management Agency, as part of its determination of whether a structure is
Pursuant to section 10(d) of the continuing effort to reduce paperwork located within an identified Special
Federal Advisory Committee Act, as and respondent burden, invites the Flood Hazard Area and whether flood
amended, notice is hereby given of the general public to take this opportunity insurance is available. Regulated
following meeting. to comment on an extension, without lending institutions, federal agency
change, of a currently approved lenders, the Federal National Mortgage
The meeting will be closed to the
information collection. In accordance Association, the Federal Home Loan
public in accordance with the
with the Paperwork Reduction Act of Mortgage Corporation, and the
provisions set forth in sections
1995, this notice seeks comments Government National Mortgage
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
concerning this form which is used by Association must complete this form for
as amended. The contract proposals and
regulated lending institutions, federal any loan made, increased, extended,
the discussions could disclose
agency lenders, the Federal National renewed or purchased by these entities.
confidential trade secrets or commercial
Mortgage Association, the Federal Home The requirement for federally regulated
property such as patentable material,
Loan Mortgage Corporation, and the lending institutions to determine
and personal information concerning
Government National Mortgage whether a building or mobile home
individuals associated with the contract
Association. Federally regulated lending securing a loan is located in an area
proposals, the disclosure of which
institutions complete this form when having special flood hazards and
would constitute a clearly unwarranted
making, increasing, extending, renewing whether flood insurance is available has
sradovich on DSK3GMQ082PROD with NOTICES
invasion of personal privacy.
or purchasing each loan for the purpose been in effect since the enactment of the
Name of Committee: National Center for is of determining whether flood Flood Disaster Protection Act of 1973,
Advancing Translational Sciences Special insurance is required and available.
Emphasis Panel; SBIR Contract Review.
although the use of a standard form was
FEMA is responsible for maintaining the not required until the enactment of the
Date: July 25, 2018.
Time: 1:00 p.m. to 4:30 p.m.
form and making it available. Section 1365 of the NFIA. The
Agenda: To review and evaluate contract DATES: Comments must be submitted on establishment of the Standard Flood
proposals. or before August 28, 2018. Hazard Determination form has enabled
VerDate Sep<11>2014 17:58 Jun 28, 2018 Jkt 244001 PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 E:\FR\FM\29JNN1.SGM 29JNN1](https://thefederalregister.org/doc/83_FR_30883/page/2.svg)
Document Created: 2018-06-29 01:13:37
Document Modified: 2018-06-29 01:13:37
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | June 29, 2018. | |
| FR Citation | 83 FR 30757 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR